Education
About Us
Working with TipRanks
Follow Us
iTeos Therapeutics (ITOS)
NASDAQ:ITOS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 35.00M | $ 12.60M | $ 267.63M | $ 344.77M | $ 0.00 |
| Gross Profit | $ 35.00M | $ 11.70M | $ 266.82M | $ 344.16M | $ -535.00K |
| Operating Income | $ -159.53M | $ -151.10M | $ 126.32M | $ 244.90M | $ -45.24M |
| EBITDA | $ -153.09M | $ -151.10M | $ 148.38M | $ 257.08M | $ -37.84M |
| Net Income | $ -134.41M | $ -112.64M | $ 96.65M | $ 214.52M | $ -38.03M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 494.65M | $ 531.92M | $ 613.16M | $ 848.54M | $ 336.33M |
| Total Assets | $ 686.98M | $ 667.59M | $ 754.99M | $ 884.71M | $ 344.56M |
| Total Debt | $ 5.10M | $ 6.06M | $ 4.67M | $ 5.34M | $ 0.00 |
| Net Debt | $ -137.03M | $ -245.12M | $ -280.13M | $ -843.20M | $ -336.33M |
| Total Liabilities | $ 96.68M | $ 92.36M | $ 91.66M | $ 331.89M | $ 21.36M |
| Stockholders' Equity | $ 590.29M | $ 575.23M | $ 663.33M | $ 552.82M | $ 323.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -99.81M | $ -106.72M | $ -112.13M | $ 511.96M | $ -25.53M |
| Operating Cash Flow | $ -98.18M | $ -103.76M | $ -111.19M | $ 513.14M | $ -25.18M |
| Investing Cash Flow | $ -131.15M | $ 72.66M | $ -446.06M | $ -1.24M | $ -377.00K |
| Financing Cash Flow | $ 122.24M | $ 1.11M | $ 1.98M | $ 3.66M | $ 340.34M |